Bi-He Cai Selected Research

1- (4- methylpiperazin- 1- yl)- 3- (5- nitrofuran- 2- yl)prop- 2- en- 1- one

12/2022

NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bi-He Cai Research Topics

Disease

7	Neoplasms (Cancer) 12/2022 - 01/2017
3	Carcinogenesis 01/2020 - 01/2018
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2017
1	Squamous Cell Carcinoma of Head and Neck 12/2022
1	Inflammation (Inflammations) 01/2020
1	Starvation 01/2019
1	Hypoxia (Hypoxemia) 01/2018

Drug/Important Bio-Agent (IBA)

4	Polysaccharides (Glycans)IBA 10/2020 - 01/2018
3	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2020 - 01/2018
2	LigandsIBA 01/2020 - 01/2019
1	1- (4- methylpiperazin- 1- yl)- 3- (5- nitrofuran- 2- yl)prop- 2- en- 1- oneIBA 12/2022
1	Nicotinamide PhosphoribosyltransferaseIBA 12/2022
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 10/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Sialyl Lewis X AntigenIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019
1	Neuraminidase (Sialidase)IBA 01/2019
1	GangliosidesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Growth Factor ReceptorsIBA 01/2018
1	SelectinsIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	I-antigenIBA 01/2017

Therapy/Procedure

1	Therapeutics 12/2022